VOYA Investment Management’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40K Buy
+13,105
New +$52K ﹤0.01% 2474
2025
Q3
– Sell
-12,092
Closed -$34.9K – 2559
2025
Q2
$34.9K Hold
12,092
– – ﹤0.01% 2638
2025
Q1
$26K Sell
12,092
-641
-5% -$2.03K ﹤0.01% 2607
2024
Q4
$49.3K Sell
12,733
-94,900
-88% -$626K ﹤0.01% 2685
2024
Q3
$705K Buy
107,633
+40
+0% +$321 ﹤0.01% 1816
2024
Q2
$780K Sell
107,593
-24,119
-18% -$185K ﹤0.01% 1761
2024
Q1
$1,000K Buy
131,712
+120,239
+1,048% +$937K ﹤0.01% 1630
2023
Q4
$52.2K Hold
11,473
– – ﹤0.01% 2845
2023
Q3
$45.3K Buy
+11,473
New +$43.4K ﹤0.01% 2864
2019
Q2
– Sell
-1,001
Closed -$33K – 2606
2019
Q1
$33K Hold
1,001
– – ﹤0.01% 2527
2018
Q4
$59K Hold
1,001
– – ﹤0.01% 2468
2018
Q3
$140K Buy
1,001
+157
+19% +$19.1K ﹤0.01% 2433
2018
Q2
$104K Buy
+844
New +$71.7K ﹤0.01% 2517
2017
Q2
– Sell
-930
Closed -$52K – 2645
2017
Q1
$52K Hold
930
– – ﹤0.01% 2482
2016
Q4
$35K Hold
930
– – ﹤0.01% 2515
2016
Q3
$37K Hold
930
– – ﹤0.01% 2529
2016
Q2
$67K Buy
+930
New +$73.5K ﹤0.01% 2531
2015
Q4
– Sell
-631
Closed -$242K – 2569
2015
Q3
$242K Hold
631
– – ﹤0.01% 2166
2015
Q2
$262K Buy
+631
New +$264K ﹤0.01% 2347

Other funds holding LRMR

VOYA Investment Management's LRMR Position: Q2 2026 in Review

VOYA Investment Management opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 13,105 shares worth $40K. The stake represents ﹤0.01% of the portfolio and ranks #2474 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in LRMR as recently as Q2 2025.

VOYA Investment Management first reported a position in LRMR in Q2 2015 and has held it in 19 quarters since. The position peaked at $1,000K in Q1 2024. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • VOYA Investment Management held 13,105 shares of Larimar Therapeutics worth $40K as of Q2 2026.
  • Larimar Therapeutics was a new VOYA Investment Management position in Q2 2026.
  • Larimar Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2474 holding.
  • VOYA Investment Management first reported a position in Larimar Therapeutics in Q2 2015 and has held it in 19 quarters since.
  • VOYA Investment Management's Larimar Therapeutics position peaked at $1,000K in Q1 2024.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.